These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11200110)

  • 21. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
    Pötter R; Gnant M; Kwasny W; Tausch C; Handl-Zeller L; Pakisch B; Taucher S; Hammer J; Luschin-Ebengreuth G; Schmid M; Sedlmayer F; Stierer M; Reiner G; Kapp K; Hofbauer F; Rottenfusser A; Pöstlberger S; Haider K; Draxler W; Jakesz R;
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):334-40. PubMed ID: 17363187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
    Fisher B; Jeong JH; Dignam J; Anderson S; Mamounas E; Wickerham DL; Wolmark N
    J Natl Cancer Inst Monogr; 2001; (30):62-6. PubMed ID: 11773294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy.
    Fodor J; Major T; Polgár C; Tóth J; Németh G
    Neoplasma; 2000; 47(3):181-6. PubMed ID: 11043843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
    Anderson SJ; Wapnir I; Dignam JJ; Fisher B; Mamounas EP; Jeong JH; Geyer CE; Wickerham DL; Costantino JP; Wolmark N
    J Clin Oncol; 2009 May; 27(15):2466-73. PubMed ID: 19349544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and state-of-the-art indications for boost irradiation in invasive breast carcinoma.
    Polo A; Polgár C; Hannoun-Levi JM; Guinot JL; Gutierrez C; Galalae R; van Limbergen E; Strnad V
    Brachytherapy; 2017; 16(3):552-564. PubMed ID: 28377213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.
    Moran MS; Schnitt SJ; Giuliano AE; Harris JR; Khan SA; Horton J; Klimberg S; Chavez-MacGregor M; Freedman G; Houssami N; Johnson PL; Morrow M
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):553-64. PubMed ID: 24521674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.
    Bosma SC; van der Leij F; van Werkhoven E; Bartelink H; Wesseling J; Linn S; Rutgers EJ; van de Vijver MJ; Elkhuizen PH
    Breast Cancer Res Treat; 2016 Apr; 156(2):391-400. PubMed ID: 27008183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CIH-Tokyo experience with breast-conserving surgery without radiotherapy: 6.5 year follow-up results of 1462 patients.
    Kasumi F; Takahashi K; Nishimura S; Iijima K; Miyagi U; Tada K; Makita M; Iwase T; Oguchi M; Yamashita T; Akiyama F; Sakamoto G
    Breast J; 2006; 12(5 Suppl 2):S181-90. PubMed ID: 16958999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final Analysis of a Phase 2 Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
    Reshko LB; Pan J; Rai SN; Ajkay N; Dragun A; Roberts TL; Riley EC; Quillo AR; Scoggins CR; McMasters KM; Eldredge-Hindy H
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):56-65. PubMed ID: 34710520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings.
    Fisher B; Wickerham DL; Deutsch M; Anderson S; Redmond C; Fisher ER
    Semin Surg Oncol; 1992; 8(3):153-60. PubMed ID: 1496226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit of radiation boost after whole-breast radiotherapy.
    Livi L; Borghesi S; Saieva C; Fambrini M; Iannalfi A; Greto D; Paiar F; Scoccianti S; Simontacchi G; Bianchi S; Cataliotti L; Biti G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1029-34. PubMed ID: 19395193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of risk factors with the efficacy of applied therapies by breast conserving procedure in breast cancer].
    Schwegler N; Puric E
    Praxis (Bern 1994); 2003 Apr; 92(14):639-48. PubMed ID: 12723313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy.
    Touboul E; Belkacemi Y; Lefranc JP; Uzan S; Ozsahin M; Korbas D; Buffat L; Balosso J; Pene F; Blondon J
    Radiother Oncol; 1995 Feb; 34(2):105-13. PubMed ID: 7597208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.
    Fyles AW; McCready DR; Manchul LA; Trudeau ME; Merante P; Pintilie M; Weir LM; Olivotto IA
    N Engl J Med; 2004 Sep; 351(10):963-70. PubMed ID: 15342804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of escalating the boost dose for patients with involved resection margin after breast-conserving surgery.
    Park S; Ahn SD; Choi EK; Kim SS
    Jpn J Clin Oncol; 2018 Mar; 48(3):272-277. PubMed ID: 29385496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.